Human tumor-associated viruses and new insights into the molecular mechanisms of cancer

Oncogene

Volumn 27, Issue , 2008, Pages S31-S42

  Martin, D ^a   Gutkind, J S ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

AIDS malignancies; Cancer; G proteins; Signal transduction; Viral oncogenes

Indexed keywords

DNA;

CANCER GENETICS; DNA SYNTHESIS; DNA VIRUS; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENOMIC INSTABILITY; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN HERPESVIRUS 8; HUMAN T CELL LEUKEMIA VIRUS 1; MOLECULAR GENETICS; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; RETROVIRUS; REVIEW; TUMOR SUPPRESSOR GENE; TUMOR VIRUS; VIRUS INFECTION; VIRUS ONCOGENE; VIRUS TRANSMISSION; WART VIRUS;

HEPACIVIRUS; HEPATITIS B VIRUS; HERPESVIRUS 4, HUMAN; HERPESVIRUS 8, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; NEOPLASMS; ONCOGENIC VIRUSES; PAPILLOMAVIRIDAE; TUMOR VIRUS INFECTIONS;

ANIMALIA; DNA VIRUSES; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 8; HUMAN PAPILLOMAVIRUS;

EID: 72949087815     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.351     Document Type: Review

References (123)

1. Aoki Y, Jaffe ES, Chang Y, Jones K, Teruya-Feldstein J, Moore PS et al. (1999). Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood 93: 4034-4043.
2. Araujo AQ, Silva MT. (2006). The HTLV-1 neurological complex. Lancet Neurol 5: 1068-1076.
3. Arvanitakis L, Yaseen N, Sharma S. (1995). Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta 1-mediated growth inhibition in EBV-positive B cells. J Immunol 155: 1047-1056.
4. Arvanitakis L, Geras-Raaka E, Varma A, Gershengorn MC, Cesarman E. (1997). Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385: 347-350.
5. Bais C, Santomasso B, Coso O, Arvanitakis L, Raaka EG, Gutkind JS et al. (1998). G-protein-coupled receptor of Kaposi's sarcomaassociated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391: 86-89.
6. Bais C, Van Geelen A, Eroles P, Mutlu A, Chiozzini C, Dias S et al. (2003). Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/KDR. Cancer Cell 3: 131-143.
7. Beaudenon S, Kremsdorf D, Croissant O, Jablonska S, Wain-Hobson S, Orth G. (1986). A novel type of human papillomavirus associated with genital neoplasias. Nature 321: 246-249.
8. Bellows DS, Chau BN, Lee P, Lazebnik Y, Burns WH, Hardwick JM. (2000). Antiapoptotic herpesvirus Bcl-2 homologs escape caspasemediated conversion to proapoptotic proteins. J Virol 74: 5024-5031.
9. Blumberg BS. (1977). Australia antigen and the biology of hepatitis B. Science 197: 17-25.
10. Bower M, Palmieri C, Dhillon T. (2006). AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy. Curr Opin Infect Dis 19: 14-19.
11. Brown KD, Hostager BS, Bishop GA. (2001). Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1). J Exp Med 193: 943-954.
12. Bubman D, Guasparri I, Cesarman E. (2007). Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen. Oncogene 26: 4979-4986.
13. Burkitt D. (1962). A children's cancer dependent on climatic factors. Nature 194: 232-234.
14. Buynak EB, Roehm RR, Tytell AA, Bertland II AU, Lampson GP, Hilleman MR. (1976). Vaccine against human hepatitis B. JAMA 235: 2832-2834.
15. Cai X, Lu S, Zhang Z, Gonzalez CM, Damania B, Cullen BR. (2005). Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc Natl Acad Sci USA 102: 5570-5575.
16. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. (1995). Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332: 1186-1191.
17. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM et al. (1994). Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865-1869.
18. Chao DT, Korsmeyer SJ. (1998). BCL-2 family: regulators of cell death. Annu Rev Immunol 16: 395-419.
19. Chatterjee M, Osborne J, Bestetti G, Chang Y, Moore PS. (2002). Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science 298: 1432-1435.
20. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. (2008). Incidence trends for human papillomavirus-related and-unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 26: 612-619.
21. Chiou CJ, Poole LJ, Kim PS, Ciufo DM, Cannon JS, ap Rhys CM et al. (2002). Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus. J Virol 76: 3421-3439.
22. Choi YB, Nicholas J. (2008). Autocrine and paracrine promotion of cell survival and virus replication by human herpesvirus 8 chemokines. J Virol 82: 6501-6513.
23. Ciuffo G. (1907). Innesto positivo con filtrato di verruca volgare. G Ital d mal ven ed pelle 48: 12.
24. Coffin JM, Hughes SH, Varmus H. (1997). Retroviruses. Cold Spring Harbor Laboratory Press: Plainview, NY.
25. Colombo M, Kuo G, Choo QL, Donato MF, Del Ninno E, Tommasini MA et al. (1989). Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 2: 1006-1008.
26. Cotter II MA, Robertson ES. (1999). The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. Virology 264: 254-264.
27. Dienstag JL, Purcell HR, Alter HJ, Feinstone SM, Wong DC, Holland PV. (1977). Non-A, non-B post-transfusion hepatitis. Lancet 1: 560-562.
28. Dittmer D, Kedes DH. (1998). Do viral chemokines modulate Kaposi's sarcoma? Bioessays 20: 367-370.
29. Dittmer D, Lagunoff M, Renne R, Staskus K, Haase A, Ganem D. (1998). A cluster of latently expressed genes in Kaposi's sarcomaassociated herpesvirus. J Virol 72: 8309-8315.
30. Dorsam RT, Gutkind JS. (2007). G-protein-coupled receptors and cancer. Nat Rev Cancer 7: 79-94.
31. Duesberg PH, Vogt PK. (1970). Differences between the ribonucleic acids of transforming and non-transforming avian tumor viruses. Proc Natl Acad Sci USA 67: 1673-1680.
32. Dyson N, Buchkovich K, Whyte P, Harlow E. (1989a). The cellular 107 K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell 58: 249-255.
33. Dyson N, Howley PM, Munger K, Harlow E. (1989b). The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243: 934-937.
34. Ellermann V, Bang O. (1908). Experimentelle leukamie bei huhnern. Zentralbl Bakteriol Parasitenkd Infektionskr Hyg 46: 595-597.
35. Ellis M, Chew YP, Fallis L, Freddersdorf S, Boshoff C, Weiss RA et al. (1999). Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex. EMBO J 18: 644-653.
36. Epstein MA, Henle G, Achong BG, Barr YM. (1965). Morphological and biological studies on a virus in cultured lymphoblasts from Burkitt's lymphoma. J Exp Med 121: 761-770.
37. Epstein MA. (1971). The possible role of viruses in human cancer. Lancet 1: 1344-1347.
38. Epstein MA. (2001). Historical background. Philos Trans R Soc Lond B Biol Sci 356: 413-420.
39. Field N, Low W, Daniels M, Howell S, Daviet L, Boshoff C et al. (2003). KSHV vFLIP binds to IKK-gamma to activate IKK. J Cell Sci 116: 3721-3728.
40. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM et al. (1986). A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323: 643-646.
41. Fujimuro M, Wu FY, ApRhys C, Kajumbula H, Young DB, Hayward GS et al. (2003). A novel viral mechanism for dysregulation of betacatenin in Kaposi's sarcoma-associated herpesvirus latency. Nat Med 9: 300-306.
42. Ganem D, Prince AM. (2004). Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 350: 1118-1129.
43. Ganem D. (2006). KSHV infection and the pathogenesis of Kaposi's sarcoma. Annu Rev Pathol 1: 273-296.
44. Gao SJ, Boshoff C, Jayachandra S, Weiss RA, Chang Y, Moore PS. (1997). KSHV ORF K9 (vIRF) is an oncogene, which inhibits the interferon signaling pathway. Oncogene 15: 1979-1985.
45. Gasparini R, Panatto D. (2009). Cervical cancer: From Hippocrates through Rigoni-Stern to zur Hausen. Vaccine 27: A4-A5.
46. Geilen CC, Husak R, Steinhoff M. (2006). Pathogenesis and clinical manifestation of Kaposi's sarcoma. Front Radiat Ther Oncol 39: 59-67.
47. Gershengorn MC, Geras-Raaka E, Varma A, Clark-Lewis I. (1998). Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture. J Clin Invest 102: 1469-1472.
48. Grisotto MG, Garin A, Martin AP, Jensen KK, Chan P, Sealfon SC et al. (2006). The human herpesvirus 8 chemokine receptor vGPCR triggers autonomous proliferation of endothelial cells. J Clin Invest 116: 1264-1273.
49. Grossmann C, Podgrabinska S, Skobe M, Ganem D. (2006). Activation of NF-kappaB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype. J Virol 80: 7179-7185.
50. Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. (1999). Viral clearance without destruction of infected cells during acute HBV infection. Science 284: 825-829.
51. Guidotti LG, Chisari FV. (2006). Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol 1: 23-61.
52. Hickman ES, Moroni MC, Helin K. (2002). The role of p53 and pRB in apoptosis and cancer. Curr Opin Genet Dev 12: 60-66.
53. Hirschman RJ, Shulman NR, Barker LF, Smith KO. (1969). Virus-like particles in sera of patients with infectious and serum hepatitis. JAMA 208: 1667-1670.
54. Howley PM, Livingston DM. (2009). Small DNA tumor viruses: large contributors to biomedical sciences. Virology 384: 256-259.
55. Hu J, Garber AC, Renne R. (2002). The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells. J Virol 76: 11677-11687.
56. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V et al. (1997). Inhibition of death receptor signals by cellular FLIP. Nature 388: 190-195.
57. Javier RT, Butel JS. (2008). The history of tumor virology. Cancer Res 68: 7693-7706.
58. Jensen KK, Manfra DJ, Grisotto MG, Martin AP, Vassileva G, Kelley K et al. (2005). The human herpes virus 8-encoded chemokine receptor is required for angioproliferation in a murine model of Kaposi's sarcoma. J Immunol 174: 3686-3694.
59. Kadaja M, Isok-Paas H, Laos T, Ustav E, Ustav M. (2009). Mechanism of genomic instability in cells infected with the highrisk human papillomaviruses. PLoS Pathog 5: e1000397.
60. Kao JH, Chen DS. (2002). Global control of hepatitis B virus infection. Lancet Infect Dis 2: 395-403.
61. Keller SA, Schattner EJ, Cesarman E. (2000). Inhibition of NFkappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood 96: 2537-2542.
62. Kilger E, Kieser A, Baumann M, Hammerschmidt W. (1998). Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J 17: 1700-1709.
63. Knudson Jr AG. (1971). Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820-823.
64. Lecoq H. (2001). Discovery of the first virus, the tobacco mosaic virus: 1892 or 1898? C R Acad Sci III 324: 929-933.
65. Levi MJ. (2005). Classic Kaposi's sarcoma. J Am Podiatr Med Assoc 95: 586-588.
66. Levine AJ. (1997). p53, the cellular gatekeeper for growth and division. Cell 88: 323-331.
67. Lombardi L, Newcomb EW, Dalla-Favera R. (1987). Pathogenesis of Burkitt lymphoma: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts. Cell 49: 161-170.
68. Louahed J, Struyf S, Demoulin JB, Parmentier M, Van Snick J, Van Damme J et al. (2003). CCR8-dependent activation of the RAS/MAPK pathway mediates anti-apoptotic activity of I-309/CCL1 and vMIP-I. Eur J Immunol 33: 494-501.
69. Mantovani F, Banks L. (2001). The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20: 7874-7887.
70. Martin D, Galisteo R, Ji Y, Montaner S, Gutkind JS. (2008). An NF-kappaB gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia. Oncogene 27: 1844-1852.
71. Matsuoka M, Jeang KT. (2007). Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 7: 270-280.
72. McCormick C, Ganem D. (2005). The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs. Science 307: 739-741.
73. Molden J, Chang Y, You Y, Moore PS, Goldsmith MA. (1997). A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J Biol Chem 272: 19625-19631.
74. Montaner S, Sodhi A, Pece S, Mesri EA, Gutkind JS. (2001). The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B. Cancer Res 61: 2641-2648.
75. Montaner S, Sodhi A, Molinolo A, Bugge TH, Sawai ET, He Y et al. (2003). Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell 3: 23-36.
76. Montaner S, Sodhi A, Servitja JM, Ramsdell AK, Barac A, Sawai ET et al. (2004). The small GTPase Rac1 links the Kaposi sarcomaassociated herpesvirus vGPCR to cytokine secretion and paracrine neoplasia. Blood 104: 2903-2911.
77. Montaner S, Sodhi A, Ramsdell AK, Martin D, Hu J, Sawai ET et al. (2006). The Kaposi's sarcoma-associated herpesvirus G proteincoupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma. Cancer Res 66: 168-174.
78. Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E. (1995). The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80: 389-399.
79. Nakamoto Y, Guidotti LG, Kuhlen CV, Fowler P, Chisari FV. (1998). Immune pathogenesis of hepatocellular carcinoma. J Exp Med 188: 341-350.
80. Nicholas J, Ruvolo VR, Burns WH, Sandford G, Wan X, Ciufo D et al. (1997). Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat Med 3: 287-292.
81. Offermann MK. (2007). Kaposi sarcoma herpesvirus-encoded interferon regulator factors. Curr Top Microbiol Immunol 312: 185-209.
82. Parkin DM. (2006). The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118: 3030-3044.
83. Pauk J, Huang ML, Brodie SJ, Wald A, Koelle DM, Schacker T et al. (2000). Mucosal shedding of human herpesvirus 8 in men. N Engl J Med 343: 1369-1377.
84. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. (1980). Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77: 7415-7419.
85. Radkov SA, Kellam P, Boshoff C. (2000). The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med 6: 1121-1127.
86. Rainbow L, Platt GM, Simpson GR, Sarid R, Gao SJ, Stoiber H et al. (1997). The 222-to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virol 71: 5915-5921.
87. Rosenkilde MM, Kledal TN, Holst PJ, Schwartz TW. (2000). Selective elimination of high constitutive activity or chemokine binding in the human herpesvirus 8 encoded seven transmembrane oncogene ORF74. J Biol Chem 275: 26309-26315.
88. Rosenkilde MM, Smit MJ, Waldhoer M. (2008). Structure, function and physiological consequences of virally encoded chemokine seven transmembrane receptors. Br J Pharmacol 153Suppl 1: S154-S166.
89. Rous P. (1910). A transmissible avian neoplasm (sarcoma of the common fowl). pp 696-705.
90. Rous P. (1911). A sarcoma of the fowl transmissible by an agent separable from the tumor cells. pp 397-411.
91. Russo JJ, Bohenzky RA, Chien MC, Chen J, Yan M, Maddalena D et al. (1996). Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci USA 93: 14862-14867.
92. Safai B. (1987). Pathophysiology and epidemiology of epidemic Kaposi's sarcoma. Semin Oncol 14: 7-12.
93. Sarid R, Sato T, Bohenzky RA, Russo JJ, Chang Y. (1997). Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue. Nat Med 3: 293-298.
94. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. (1990). The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136.
95. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. (1993). The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75: 495-505.
96. Seo T, Lee D, Shim YS, Angell JE, Chidambaram NV, Kalvakolanu DV et al. (2002). Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus interacts with a cell death regulator, GRIM19, and inhibits interferon/retinoic acid-induced cell death. J Virol 76: 8797-8807.
97. Sharp TV, Boshoff C. (2000). Kaposi's sarcoma-associated herpesvirus: from cell biology to pathogenesis. IUBMB Life 49: 97-104.
98. Sodhi A, Montaner S, Patel V, Zohar M, Bais C, Mesri EA et al. (2000). The Kaposi's sarcoma-associated herpes virus G proteincoupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. Cancer Res 60: 4873-4880.
99. Sodhi A, Montaner S, Miyazaki H, Gutkind JS. (2001). MAPK and Akt act cooperatively but independently on hypoxia inducible factor-1alpha in rasV12 upregulation of VEGF. Biochem Biophys Res Commun 287: 292-300.
100. Sodhi A, Montaner S, Gutkind JS. (2004a). Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis? FASEB J 18: 422-427.
101. Sodhi A, Montaner S, Patel V, Gomez-Roman JJ, Li Y, Sausville EA et al. (2004b). Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor. Proc Natl Acad Sci USA 101: 4821-4826.
102. Sodhi A, Chaisuparat R, Hu J, Ramsdell AK, Manning BD, Sausville EA et al. (2006). The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. Cancer Cell 10: 133-143.
103. Stallone G, Schena A, Infante B, Di Paolo S, Loverre A, Maggio G et al. (2005). Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med 352: 1317-1323.
104. Staskus KA, Sun R, Miller G, Racz P, Jaslowski A, Metroka C et al. (1999). Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. J Virol 73: 4181-4187.
105. Stehelin D, Varmus HE, Bishop JM, Vogt PK. (1976). DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature 260: 170-173.
106. Tang H, Oishi N, Kaneko S, Murakami S. (2006). Molecular functions and biological roles of hepatitis B virus x protein. Cancer Sci 97: 977-983.
107. Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N et al. (2000). The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 284: 450-456.
108. Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, Harrington Jr W et al. (2009). Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol 27: 453-459.
109. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. (1977). Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 50: 481-492.
110. Verschuren EW, Klefstrom J, Evan GI, Jones N. (2002). The oncogenic potential of Kaposi's sarcoma-associated herpesvirus cyclin is exposed by p53 loss in vitro and in vivo. Cancer Cell 2: 229-241.
111. Vider-Shalit T, Fishbain V, Raffaeli S, Louzoun Y. (2007). Phasedependent immune evasion of herpesviruses. J Virol 81: 9536-9545.
112. Vogelstein B, Kinzler KW. (2004). Cancer genes and the pathways they control. Nat Med 10: 789-799.
113. Vogt PK. (2009). A humble chicken virus that changed biology and medicine. Lancet Oncol 10: 96.
114. Wang J, Chenivesse X, Henglein B, Brechot C. (1990). Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature 343: 555-557.
115. Weinberg RA. (1997). The cat and mouse games that genes, viruses, and cells play. Cell 88: 573-575.
116. Wood C, Harrington Jr W. (2005). AIDS and associated malignancies. Cell Res 15: 947-952.
117. Xie J, Ajibade AO, Ye F, Kuhne K, Gao SJ. (2008). Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways. Virology 371: 139-154.
118. Xu Y, Rodriguez-Huete A, Pari GS. (2006). Evaluation of the lytic origins of replication of Kaposi's sarcoma-associated virus/human herpesvirus 8 in the context of the viral genome. J Virol 80: 9905-9909.
119. Yang TY, Chen SC, Leach MW, Manfra D, Homey B, Wiekowski M et al. (2000). Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J Exp Med 191: 445-454.
120. Yoshida M. (2001). Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol 19: 475-496.
121. Young LS, Rickinson AB. (2004). Epstein-Barr virus: 40 years on. Nat Rev Cancer 4: 757-768.
122. Zhong W, Wang H, Herndier B, Ganem D. (1996). Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc Natl Acad Sci USA 93: 6641-6646.
123. zur Hausen H. (2009). Papillomaviruses in the causation of human cancers-a brief historical account. Virology 384: 260-265.